Searched for
PHARMACEUTICAL TRADEMARK DISPUTE
Delhi High Court rules in favour of Dr Reddy's Labs in trademark row with RazentaThe Delhi High Court ordered the removal of Razenta Pharmaceuticals' Daplogin trademark. This decision came as the mark was deemed deceptiv...- Glenmark launches generic Olanzapine injection in USGlenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States, offering a treatment for schizophreni...
- Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...
- NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedingsThe NCLAT has ruled in favor of Lyka Labs. It overturned a previous NCLT decision. Modi Lifecare Industries must now pay Rs 63 lakh within ...
- Sun Pharma gets relief in trademark case from High CourtThe Bombay High Court has ruled in favour of Sun Pharmaceutical Industries. The court has restrained United Biotech from using a similar tr...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- Sun Pharma wins trademark case against Navi Mumbai companyThe Bombay High Court has ruled against a Navi Mumbai drugmaker. The court prohibited the use of brand names 'Absun' and 'Absun Pharma'. Th...
- Delhi HC refuses to halt Sun Pharma’s Pruease tables sales over trademark rowThe Delhi High Court has denied RSPL Health's petition to stop Sun Pharmaceutical Industries from selling Pruease tablets, a constipation r...
- Indian domain name plaints up 60% in 2015; country ranks 11th, US tops WIPO listSimply put, cybersquatting is the abusive registration of trademarks as domain names, where an individual or company attempts to usurp the ...
- Delhi High Court stays transfer of IPR cases to lower courtsThe Delhi High Court will for now not transfer out any pending intellectual property rights cases to lower courts irrespective of their pec...
- HC reserves order on Novartis-Cipla drug disputeThe Delhi High Court has reserved its verdict on a dispute between pharma firms Novartis and Cipla over manufacturing of the drug Indacater...
- Nirmala Sitharaman discusses intellectual property rights related issues with officialsThe Obama administration had been strongly criticising India's investment climate and IPR laws, especially in the pharmaceutical and solar ...
- In desi Viagra market, companies fight over namesSettling a trademark dispute between two major desi viagra players on Wednesday, the IPAB disallowed them from using two trademarks.
- Patent war: Indian drug firms hike legal expense to take on global peersThe domestic pharma industry has spent 1,963 crore on legal cases and opinions so far this fiscal, a 21% increase over last year.
- Indian Drugs Manufacturing Association reviewing government directive on drug brandingIndian Drugs Manufacturing Association will take a call on legal action in its meeting on Friday after a new directive by the health minist...
- US threatens to take India to WTO over Nexavar GenericThe US has threatened to drag India to the WTO for issuing the firstever compulsory licence to a domestic company to manufacture generic ve...
- US ups the ante on Nexavar Generic, threatens to take India to WTOThe US House of Representatives and the US Patent and Trademark Office (USPTO) have threatened to drag India to the WTO.
- Sun Pharma shares plunge on damages sought by WyethShares of Sun Pharmaceutical dropped nearly 3% as the company said that US-based Wyeth has sought damages worth $960 mn in a patent dispute.
- Wyeth makes $960 mn claims on Protonix patent case: Sun PharmaSun Pharma said US-based Wyeth Pharma has sought damages worth $960 mn related to their ongoing patent dispute over generic version of Prot...
- Zydus, Teva end patent disputesAhmedabad-based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients (APIs)...
Load More
